PHS
PLAN

PFM Health Sciences’s Anaplan, Inc. PLAN Stock Holding History

PFM Health Sciences’s Portfolio PLAN Stock Details PLAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-33,587
Closed -$891K – 123
2018
Q4 		$891K Buy
+33,587
New +$830K 0.02% 89

Other funds holding PLAN

Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
MCAI
Meritech Capital Associates IV Palo Alto, California $51.9M AUM 64.09% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCPEM
Bain Capital Public Equity Management Boston, Massachusetts $1.05B AUM 25.71% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

PFM Health Sciences's PLAN Position: Q1 2019 in Review

PFM Health Sciences sold out of Anaplan, Inc. (PLAN) in Q1 2019, closing a stake of 33,587 shares — an estimated $891K sold.

PFM Health Sciences first reported a position in PLAN in Q4 2018 and held it in 1 quarter. The position peaked at $891K in Q4 2018. 126 funds tracked by Wall St. Rank hold PLAN as of Q1 2019.

  • PFM Health Sciences reported no remaining Anaplan, Inc. position as of Q1 2019 after selling out during the quarter.
  • PFM Health Sciences sold 33,587 Anaplan, Inc. shares in Q1 2019, an estimated $891K.
  • PFM Health Sciences first reported a position in Anaplan, Inc. in Q4 2018 and held it in 1 quarter.
  • PFM Health Sciences's Anaplan, Inc. position peaked at $891K in Q4 2018.
  • 126 funds tracked by Wall St. Rank held Anaplan, Inc. as of Q1 2019.

Based on PFM Health Sciences's 13F filing for Q1 2019, filed 15 May 2019.